Develops drugs for fibromyalgia and migraine.
Jun 2026Revenue $29.1M/yrExpenses $195M/yr
No trendCash runway ≈ 1.1 years from Jun 2026
Figures by year
When will Tonix Pharmaceuticals Holding be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $29.1M and expenses $195M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $13.1M | $139M | −$126M |
| Dec 2024 | $10.1M | $147M | −$137M |
| Dec 2023 | $7.77M | $126M | −$118M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.